Vaxcyte

Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.

Funding reportedLast round: Post ipo equity

BiopharmaSan Carlos, United States

What company datasets say Vaxcyte raised

Funding, as reported

Reported in all$2.3Bin dollars

Rounds11

Last roundPost ipo equity

Last round dateJan 2024

Investors listed12

From Vaxcyte's own website: 1 on the team.

Investors who name them

Each firm lists Vaxcyte on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Startups like it

Add your raise, your deck and your story, and put Vaxcyte in front of investors. Or tell us what we have wrong.